Sublimaze and Maxipime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sublimaze (fentanyl citrate) and Maxipime (cefepime hydrochloride). Common drug interactions include platelet count decreased among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Sublimaze and Maxipime. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Sublimaze?

Sublimaze has active ingredients of fentanyl citrate. eHealthMe is studying from 560 Sublimaze users. Check the latest studies of Sublimaze.

What is Maxipime?

Maxipime has active ingredients of cefepime hydrochloride. eHealthMe is studying from 4,279 Maxipime users. Check the latest studies of Maxipime.



On Jul, 17, 2026

56 people who take Sublimaze and Maxipime together, and have interactions are studied.

Sublimaze and Maxipime drug interactions.

What are the common drug interactions of Sublimaze and Maxipime, by gender? *:

female:

  1. Platelet count decreased
  2. Pain in extremity
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  6. Hypoxia (low oxygen in tissues)
  7. Peripheral swelling
  8. Respiratory failure (inadequate gas exchange by the respiratory system)
  9. Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
  10. Abdominal pain

male:

  1. Pyrexia (fever)
  2. Diarrhoea
  3. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  4. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  5. Night sweats (sweating in night)
  6. Productive cough
  7. Pruritus (severe itching of the skin)
  8. Pseudomonas test positive
  9. Secretion discharge
  10. Sputum discoloured

What are the common drug interactions of Sublimaze and Maxipime, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Hypertension (high blood pressure)
  2. Infection
  3. Cardiac failure
  4. Overdose
  5. Pulmonary hypertension (increase in blood pressure in the lung artery)
  6. Respiratory failure (inadequate gas exchange by the respiratory system)

10-19:

  1. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  2. Blood creatinine increased
  3. Blood lactic acid increased
  4. Blood urea increased
  5. Bone marrow failure
  6. Bradycardia (abnormally slow heart action)
  7. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  8. Cytokine storm (over-protective immune response that can actually be fatal)
  9. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  10. Haematuria (presence of blood in urine)

20-29:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Death
  5. Decreased activity
  6. Emotional distress
  7. Fear
  8. Impaired work ability
  9. Pain
  10. Quality of life decreased

30-39:

  1. Asthenia (weakness)
  2. Chest discomfort
  3. Chest pain
  4. Cough
  5. Decreased appetite
  6. Diarrhoea
  7. Dyspnoea (difficult or laboured respiration)
  8. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  9. Headache (pain in head)
  10. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

40-49:

  1. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  2. Drug ineffective
  3. Infection
  4. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. B-cell lymphoma (blood cancer affecting b cells)
  7. B-cell lymphoma recurrent (blood cancer affecting b cells-recurrent)
  8. Bacteraemia (presence of bacteria in the blood)
  9. Bacterial sepsis
  10. Disseminated intravascular coagulation (systemic activation of blood coagulation)

50-59:

  1. Perirectal abscess
  2. Rectal abscess (pus in rectum)
  3. Renal failure (kidney dysfunction)
  4. Renal tubular necrosis (death of kidney tubules)
  5. Retroperitoneal abscess (a collection of pus between the peritoneum and the posterior abdominal wall. retroperitoneal. behind the peritoneum)
  6. Tooth abscess (pus formation in tooth)
  7. Urinary tract infection
  8. Urine output decreased
  9. Vaginal abscess
  10. Febrile neutropenia (fever with reduced white blood cells)

60+:

  1. Diarrhoea
  2. Anaemia (lack of blood)
  3. Bacteraemia (presence of bacteria in the blood)
  4. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  5. Device failure
  6. Hypoglycaemia (deficiency of glucose in the bloodstream)
  7. Hypokalaemia (low potassium)
  8. Pneumonia
  9. Small intestinal obstruction (blockage in small intestine)
  10. Alanine aminotransferase increased

What are the existing conditions these people have? *

  1. Pain: 17 people, 30.36%
  2. Hypotension (abnormally low blood pressure): 13 people, 23.21%
  3. Constipation: 13 people, 23.21%
  4. Cough: 12 people, 21.43%
  5. Stress And Anxiety: 12 people, 21.43%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 17.86%
  7. Nausea (feeling of having an urge to vomit): 10 people, 17.86%
  8. Pain In Extremity: 10 people, 17.86%
  9. Sedation: 8 people, 14.29%
  10. Depression: 8 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Sublimaze and Maxipime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sublimaze and Maxipime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sublimaze:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Maxipime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sublimaze and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Maxipime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fentanyl citrate and cefepime hydrochloride (the active ingredients of Sublimaze and Maxipime, respectively), and Sublimaze and Maxipime (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: